Evidence map›Paper›PMID 36222427›Full record

ReviewNatural product reports2023

The 'emodin family' of fungal natural products-amalgamating a century of research with recent genomics-based advances.

Kate M J de Mattos-Shipley, Thomas J Simpson

Erratum issuedOpen access · hybridAbstract readReview
In one paragraph

Review in Natural product reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Opportunistic pathogenicity in fungi can transcend species boundaries.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kate M J de Mattos-ShipleySchool of Biological Sciences, University of Bristol, 24 Tyndall Avenue, Bristol, BS8 1TQ, UK. kate_dms@hotmail.com.ORCID 0000-0002-0888-490X
Thomas J SimpsonSchool of Chemistry, University of Bristol, Cantock's Close, Bristol, BS8 1TS, UK.ORCID 0000-0003-0777-1935
University of Bristol · GB

Funding

Medical Research Council MR/N029909/1
6 · The paper itself

Abstract

Covering: up to 2022A very large group of biosynthetically linked fungal secondary metabolites are formed

Indexed as

Biological ProductsEmodinXanthonesAnthraquinonesGenomicsAnthraquinonesBiological ProductsEmodinXanthones

Identifiers

PMID36222427
PMCPMC9890505
OpenAlexW4304758085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.